Webinar

Contents

Chair

Pierluigi Toniutto

Assistant Professor of Medicine, Director of Hepatology and Liver Transplant Unit, University of Udine, Udine, Italy.

Speaker(s)

Vincenzo Mazzaferro

Full Professor of Surgery at the Department of Oncology of the University of Milan and Director of the Gastro-Intestinal Surgery and Liver Transplantation Unit at the Istituto Nazionale Tumori (National Cancer Institute), Milan, Italy.

Topic: Liver surgery: any chance to surpass the current limitations in treating hepatocellular carcinoma?

Davide Citterio

Medical Doctor of HPB Surgery, Hepatology and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.

Topic: Liver surgery: any chance to surpass the current limitations in treating hepatocellular carcinoma?

Jessica Zucman-Rossi

Professor of Oncology in University Paris Descartes and director of the Inserm Unit "Functional Genomic of Solid Tumors", Paris, France.

Topic: Biochemical, genetic, and histological markers to select patients with hepatocellular carcinoma for liver transplantation

Myron E. Schwartz

The Henry Kaufmann Professor of Surgery, and Director of Liver Surgery, Recanati/Miller Transplantation Institute, The Mount Sinai Medical Center, New York, USA.

Topic: The changing face of hepatocellular carcinoma: Implications for surgical management

Patrizia Burra

Professor of Gastroenterology and Head of the Multivisceral Transplant Unit, University Hospital Padua, Italy.

Topic: The changing epidemiology and risk factors for hepatocellular carcinoma

Umberto Cillo

Professor of General Surgery from the University of Padova, Director at the University of Padova, Padua, Italy.

Topic: New horizons of downstaging treatments before liver transplant

Jan Lerut

Professor Emeritus of Surgery, Director of the Starzl Abdominal Transplant Unit, University Hospitals Saint Luc and UCL Transplant Centre in Brussels, and Past President of European Society of Organ Transplantation and International Society of Liver Transplantation, Brussels, Belgium.

Topic: Liver transplantation and hepatocellular carcinoma: from extended to advanced criteria

Nobuhisa Akamatsu

Lecturer of Faculty of Medicine, The University of Tokyo, Tokyo, Japan.

Topic: The management of recipient after liver transplantation for hepatocellular carcinoma in the era of expanded criteria
Programme
Programme
  1. Time (Rome)
  1. Speakers
  1. Topics
  1. 14:00 - 14:10
  1. Pierluigi Toniutto
  1. Welcome Speech
  1. 14:10 - 14:30
  1. Patrizia Burra
  1. The changing epidemiology and risk factors for hepatocellular carcinoma
  1. 14:30 - 14:50
  1. Myron E. Schwartz
  1. The changing face of hepatocellular carcinoma: implications for surgical management
  1. 14:50 - 15:10
  1. Vincenzo Mazzaferro, Davide Citterio
  1. Liver surgery: any chance to surpass the current limitations in treating hepatocellular carcinoma?
  1. 15:10 - 15:25
  1. Pierluigi Toniutto
  1. Discussion (Q&A)
  1. 15:25 - 15:45
  1. Jessica Zucman-Rossi
  1. Biochemical, genetic, and histological markers to select patients with hepatocellular carcinoma for liver transplantation
  1. 15:45 - 16:05
  1. Umberto Cillo
  1. New horizons of downstaging treatments before liver transplant
  1. 16:05 - 16:25
  1. Jan Lerut
  1. Liver transplantation and hepatocellular carcinoma: from extended to advanced criteria
  1. 16:25 - 16:45
  1. Nobuhisa Akamatsu
  1. The management of recipient after liver transplantation for hepatocellular carcinoma in the era of expanded criteria
  1. 16:45 - 17:00
  1. Pierluigi Toniutto
  1. Discussion (Q&A)

Moments

Presentation

Pierluigi Toniutto, Assistant Professor of Medicine, Director of Hepatology and Liver Transplant Unit, University of Udine, Udine, Italy.
Topic: Warm welcome speech to the webinar Liver Transplantation for Hepatocellular Carcinoma: Up to Date

NaN

Patrizia Burra, Professor of Gastroenterology and Head of the Multivisceral Transplant Unit, University Hospital Padua, Italy.
Topic: The changing epidemiology and risk factors for hepatocellular carcinoma

NaN

Myron E. Schwartz, The Henry Kaufmann Professor of Surgery, and Director of Liver Surgery, Recanati/Miller Transplantation Institute, The Mount Sinai Medical Center, New York, USA.
Topic: The changing face of hepatocellular carcinoma: implications for surgical management

NaN

Davide Citterio, Medical Doctor of HPB Surgery, Hepatology and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.
Topic: Liver surgery: any chance to surpass the current limitations in treating hepatocellular carcinoma?

NaN

Heated discussion section of the webinar Liver Transplantation for Hepatocellular Carcinoma: Up to Date

NaN

Umberto Cillo, Professor of General Surgery from the University of Padova, Director at the University of Padova, Padua, Italy.
Topic: New horizons of downstaging treatments before liver transplant

NaN

Jessica Zucman-Rossi, Professor of Oncology in University Paris Descartes and director of the Inserm Unit "Functional Genomic of Solid Tumors", Paris, France.
Topic: Biochemical, genetic, and histological markers to select patients with hepatocellular carcinoma for liver transplantation

NaN

Jan Lerut, Professor Emeritus of Surgery, Director of the Starzl Abdominal Transplant Unit, University Hospitals Saint Luc and UCL Transplant Centre in Brussels, and Past President of European Society of Organ Transplantation and International Society of Liver Transplantation, Brussels, Belgium.
Topic: Liver transplantation and hepatocellular carcinoma: from extended to advanced criteria

NaN

Nobuhisa Akamatsu, Lecturer of Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Topic: The management of recipient after liver transplantation for hepatocellular carcinoma in the era of expanded criteria

NaN
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/